The structure of the title ionic compound, (C 5 H 6 N 5 ) 2 [Cu-(C 2 O 4 ) 2 ]Á2H 2 O, consists of a centrosymmetric copper(II) oxalate dianion, two monoprotonated molecules of the adenine analog 7-amino-1,2,4-triazolo[1,5-a]pyrimidine (7atp) and two water molecules of crystallization. The Cu II ion, located on an inversion center, exhibits a sligthly distorted square-planar coordination geometry, in which two oxalate anions bind in a bidentate fashion. The triazolopyrimidine ligand is protonated at the N atom in position 4, instead of its most basic N atom in position 3. This fact may be explained by the network stability, which is provided through the formation of a two-dimensional wave-like network parallel to (501) by N-HÁ Á ÁO, O-HÁ Á ÁN and O-HÁ Á ÁO hydrogen bonds. These nets are further connected via C-HÁ Á ÁO interactions.
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Comment
In the recent years, the rational design and synthesis of biomimetic systems based on the interaction of biologically relevant molecules with inorganic species has aroused a remarkable research interest. The study of these systems not only stems from the desire to better understand the complex interactions often present in different molecular biorecognition processes (Hannon, 2007) , but also to afford a powerful tool for the improvement of pharmaceutical agents (Legraverend & Grierson, 2006) . 1,2,4-triazolo[1,5-a]pyrimidines may be used as purine analogs to obtain new biomimetic systems with interesting physical and biological properties, which might differ from those of purine-based systems due to their slightly different atomic arrangement. Previous studies revealed that the coordination chemistry of 1,2,4-triazolo[1,5-a]pyrimidine derivatives displays great versatility, binding metal ions in several different ways, either in a monodentate (usually through the N atom in position 3), or in a bidentate fashion, bridging metal atoms and leading to binuclear or polynuclear species with interesting metal-metal interactions Caballero et al., 2011) . However, few examples containing a protonated form of the triazolopyrimidine have been reported, most of them bearing the 5,7-dimethylated derivative (Szlyk et al., 2002; Maldonado et al., 2005; Maldonado et al., 2008) . To the best of our knowledge, the copper(II) complex reported herein is the only one obtained with the protonated form of the 7-amino derivative, 7-amino-1,2,4-triazolo[1,5-a]pyrimidine (7atp).
The molecular structure of the title compound is illustrated in Fig (Table 1 and Fig. 2 ). These nets are further connected via C-H···O interactions (Table 1) .
Experimental
The title compound was prepare by dissolving K 2 [Cu(ox) 2 ].2H 2 O (0.16 mmol, 0.057 g) in 10 ml of a hot aqueous solution of potassium oxalate dihydrated (0.16 mmol, 0.029 g). 10 ml of an aqueous solution of 7-amino-1,2,4-triazolo[1,5-a]pyrimidine (7atp) (0.032 mmol, 0.043 g) was then added and the colour changed from blue to green. The solution was stirred at 50° C for 30 min, and then left standing at room temperature. After one day, prismatic dark-green crystals of the polymeric complex {[Cu(ox)(7atp) 2 ].3H 2 O} n were formed and filtered off. After 3-4 days needle-shaped blue crystals of the title complex were isolated and used for the present X-ray diffraction studies.
Refinement
The supplementary materials sup-2 Figures   Fig. 1 . ORTEP representation of the asymmetric unit of the title compound, showing the atom labels and displacement ellipsoids drawn at the 50% probability level. 
